Advertisement

Topics

Aclaris buys Confluence Life Sciences for $20mm plus $80mm in earn-outs

15:40 EDT 9 Aug 2017 | Elsevier Business Intelligence

Aclaris Therapeutics Inc. acquired private kinase inhibitor firm Confluence Life Sciences Inc. for $20mm up front ($10mm in c...

Original Article: Aclaris buys Confluence Life Sciences for $20mm plus $80mm in earn-outs

NEXT ARTICLE

More From BioPortfolio on "Aclaris buys Confluence Life Sciences for $20mm plus $80mm in earn-outs"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...